Triäthylenmelamin (Tem), ein neuer Stoff zur Behandlung von Leukämien

Publisher Website

1 June 1952

journal article
Published by Springer Nature in Journal of Molecular Medicine

Vol. 30 (23-24) , 537-547
https://doi.org/10.1007/bf01472179

Abstract

No abstract available

Keywords

LEUKEMIA/THERAPY

This publication has 3 references indexed in Scilit:

New Cytotoxic Agents with Tumour-Inhibitory Activity
Nature, 1950
Triethylene melamine in the treatment of Hodgkin's disease and allied neoplasms.
1950
RETARDATION OF TUMOR GROWTH IN MICE BY ORAL ADMINISTRATION OF ETHYLENIMINE DERIVATIVES
1950